Clinical Trials in Harrow, London
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis
Regeneron Pharmaceuticals132 enrolled3 locationsNCT06836609
Recruiting
Not Applicable
Beyond TME Origins
CarcinomaNeoplasmsAdenocarcinoma
Imperial College London383 enrolled4 locationsNCT02292641